We would love to hear your thoughts about our site and services, please take our survey here.
Looks like RF buy?
I need at least 22p as most of my purchases are at that level and I could have sold for double that.
One valuable lesson, don’t listen to what any member of the company says. Just focus on the share price movements. If James Cheek did what he said he was going to do, then it would be well over 50p now. Instead he has virtually done nothing in 6 months.
I don’t know what to do. I have been in this share like 99% of the time since June 2021 when it was 64p.😂 Now massively down and need it to go up many times just to break even.
Https://www.linkedin.com/posts/joanneinglis_genedrive-activity-7178340576516349952-jhqt?utm_source=share&utm_medium=member_ios
Looks like at least one person is doing something today. Surely these employees will want Genedrive to stay around to finish what they started? That is my only hope now.
Eureka01 that is the thing even before then huge buy days and the price down. I believe Genedrive has had the highest percentage buys in the last week of all the stocks on AIM. Many millions of shares bought and the price down. Just shows you how bad the RF deal is, people can keep buying millions of shares every week at the lowest price in the company history. I didn’t realise it was that bad. No wonder they call it a death spiral finance. Genedrive would have been better off doing a discount placing lst yeR at 95% as the trades since then would have it now over 50p.
I reckon the share price would have been 50p with the exact same trades taking away RF ones now but instead it is 3.125p. That is why I am hoping RF are done crashing it soon.
I think since RF have come in it has gone from 35p to 3.125p with like 80% buys. I never realised how bad the RF deal was until I kept seeing big buys and end the week massively down. It seems the more buys there are the more it crashes.
Raffs60 that has been the case since RF came in. You need like £600K of buys with no PI sells for it to go up in a week these days.
This weeks trading shows how damaging the RF deal has been. Huge buys and lots of buys and the share price down. If they could somehow get rid of this RF drawdown in next RNS, get a premium placing done at say 6p, then we could see it rocketing back into the 30’s. Surely they put options so they make money when it is way above 6p?
My only hope is surely it will start going back up again at some stage? If David Budd could make this rocket to 299p, then surely James Cheek can get it to around the 12-13p it was when he joined.
I have been in since I bought a decent chunk at 64p in 2021. What a disaster this has been. Every year I think I it will surge back to those days. Last years interims hinted at a huge market for both there products and yet the share price has crashed and the new CEO who was brought into improve the share price has crashed the share price around 80% since he came.
Https://www.bmh.manchester.ac.uk/stories/genetic-testing-secondary-stroke/In May 2023, NICE produced draft guidance that recommends genotype testing if treatment with clopidogrel is being considered. Final guidance in due to be released in September 2023. We hope that this test will soon be able to be used by clinicians for this purpose.
.........
That is what annoys me more. I was waiting for that news.
The stroke NICE recommendation was actually originally due for September last year and they were confident on that.
He also told us special commissioning is happening and FDA partner news of contracts being ready to sign was coming and that was after the November presentation. Now we are nearly in April and no news on any of that. He could have come out and said it has been delayed at least. I wonder if we finally find out on everything he said that was due around December and January time in the results RNS. The worst part is I held for the FDA partner news and Stroke NICE recommendation that was before due in December 22nd and now is April 3rd. I would have sold out if they said it was delayed.
I am annoyed as he misled investors saying FDA partner news and Stroke recommendation news was due and now we are nearly in April and now we know the Stroke test that was due in December to January time, will be April 3rd now. I never expected them to delay something that was massively delayed to begin with. :(
Mean seen recently. What makes it worse is he expected so much news and delivered virtually nothing in over six months. He has made David Budd look like a productive CEO.
Presentation is on the 5th April at 10AM. I wish I never saw his profile which showed he was here to improve the share price. He must have been the worst performing new CEO in AIM history. I cannot recall any other stock having a new CEO and it continually crashed every month. What makes it worse is I now think he was brought in with a job to crash the share price as sewn recently when it went up and they released an RNS to crash it.
I reckon now it will only go up just before close before results day.
I reckon they are doing the investor presentation soon after the Stroke test news for good PR.